Article

Osteoarthritis Summit Set For June 2011

For the first time, Hospital for Special Surgery will host an international Osteoarthritis Summit in June 2011 that will bring together a comprehensive multidisciplinary group of world renowned scientists, thought-leaders and industry representatives from the US, Canada, and Europe.

For the first time, Hospital for Special Surgery will host an international Osteoarthritis Summit in June 2011 that will bring together a comprehensive multidisciplinary group of world renowned scientists, thought-leaders and industry representatives from the US, Canada, and Europe.

The goal will be to discuss aspects of OA and develop a consensus document on future directions for OA research, prevention, and treatment.

“Public health data indicate that the prevalence, impact, and economic consequences of osteoarthritis are expected to rise dramatically within the next several decades,” said Steven Goldring, M.D., chief scientific officer at Hospital for Special Surgery and co-director of the conference, in a press release. “Clearly, understanding and preventing this disease is an urgent research challenge."

Timothy Wright, Ph.D., Kirby Chair of Orthopedic Biomechanics at HSS, is also the co-director of the event.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.